{
    "Trade/Device Name(s)": [
        "MCT-DiabetesTM",
        "MCT DiabetesTM, Version 2.0"
    ],
    "Submitter Information": "MyCareTeam, Inc.",
    "510(k) Number": "K073699",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070593"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "JQP"
    ],
    "Summary Letter Date": "December 31, 2007",
    "Summary Letter Received Date": "December 31, 2007",
    "Submission Date": "December 31, 2007",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.2100"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Calculator/data processing module, for clinical use"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Blood Glucose"
    ],
    "Specimen Type(s)": [],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Various home-use blood glucose monitors by Roche Diagnostics, Bayer, BD, Johnson & Johnson, Abbott, Nova Biomedical",
        "Personal computer"
    ],
    "Method(s)/Technology(ies)": [
        "Data management software",
        "Internet-based software"
    ],
    "Methodologies": [
        "Data review",
        "Data analysis",
        "Data evaluation"
    ],
    "Submission Type(s)": [
        "Software",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for MCT-Diabetes Internet-based software for managing and analyzing blood glucose data from personal glucose monitors",
    "Indications for Use Summary": "Serves as an interface between personal glucose monitoring devices and a health management database to assist in the review, analysis, and evaluation of blood glucose test results for home and professional healthcare settings",
    "fda_folder": "Clinical Chemistry"
}